Paragon Care Ltd (ASX: PGC) Share Price and News
Price
$0.42
Movement
0.01 (+2.44%)
as at 15 May - Closed (20 mins delayed)
52 Week Range
$0.345 - $0.59
1 Year Return
+18.31%
Paragon Care Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$678.68 million
P/E Ratio
33.60
Dividend Yield
0.00%
Shares Outstanding
1.66 billion
Earnings per share
0.013
Dividend per share
0.01
Year To Date Return
-12.50%
Earnings Yield
2.98%
Franking
100%
Share Price
$0.42
Day Change
0.01 (+2.44%)
52 Week Range
$0.345 - $0.59
Yesterday's Close
$0.41
Today's Open
$0.415
Days Range
$0.415 - $0.425
Volume
67,825
Avg. Volume (1 month)
296,400
Turnover
$28,384
as at 15 May - Closed
Paragon Care Ltd (ASX: PGC)
Latest News
Defensive Shares
2 ASX healthcare shares I'd buy for my portfolio
Share Gainers
The ASX small cap stocks enjoying a Bill Shorten boost
ASX Shares
Here's how I would invest $10,000 into ASX shares
Share Gainers
ALL ORDINARIES finishes higher Thursday: 8 shares you missed
Share Gainers
ALL ORDINARIES finishes higher Tuesday: 8 shares you missed
ASX Shares
Should you stay invested long-term when your ASX shares disappoint?
Share Market News
The Paragon Care share price has fallen 11% on earnings guidance
Share Fallers
Why Flight Centre, Pact, Paragon Care, & Transurban shares tumbled lower today
Growth Shares
How I'd invest $10,000 today into ASX shares
ASX Shares
Where I'd invest $10,000 into ASX shares today
Share Market News
Where I'd invest $25,000 into ASX shares today
52-Week Lows
Should you buy the beaten down shares of Challenger and 2 other All Ords shares?
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 18 Sep 2023 | $0.0060 | 100.00% | Final | 06 Oct 2023 |
| 14 Mar 2023 | $0.0060 | 100.00% | Interim | 05 Apr 2023 |
| 12 Sep 2022 | $0.0060 | 100.00% | Final | 04 Oct 2022 |
| 21 Mar 2022 | $0.0060 | 100.00% | Interim | 26 Apr 2022 |
| 13 Sep 2021 | $0.0100 | 100.00% | Final | 01 Oct 2021 |
| 21 Mar 2019 | $0.0110 | 100.00% | Interim | 26 Apr 2019 |
| 14 Sep 2018 | $0.0200 | 100.00% | Final | 12 Oct 2018 |
| 15 Mar 2018 | $0.0110 | 100.00% | Interim | 12 Apr 2018 |
| 07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
| 09 Mar 2017 | $0.0110 | 100.00% | Interim | 06 Apr 2017 |
| 15 Sep 2016 | $0.0140 | 100.00% | Final | 06 Oct 2016 |
| 09 Mar 2016 | $0.0080 | 100.00% | Interim | 06 Apr 2016 |
| 08 Oct 2014 | $0.0075 | 100.00% | Final | 31 Oct 2014 |
| 07 Mar 2014 | $0.0050 | 100.00% | Interim | 31 Mar 2014 |
| 04 Oct 2013 | $0.0100 | 100.00% | Final | 31 Oct 2013 |
PGC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 1st May 2025 2025-05-01T14:05:46 | Revised Securities Trading Policy | YesNo | 2:05pm | 10 | 443k |
| 31st Mar 2025 2025-03-31T08:25:23 | Final Director's Interest Notice | YesNo | 8:25am | 2 | 209k |
| 31st Mar 2025 2025-03-31T08:23:53 | Retirement of Non-Executive Director | YesNo | 8:23am | 1 | 206k |
| 27th Mar 2025 2025-03-27T17:25:03 | Change in substantial holding from WMI/WAM/WAX | YesNo | 5:25pm | 7 | 251k |
| 21st Mar 2025 2025-03-21T08:22:35 | Initial Director's Interest Notice | YesNo | 8:22am | 2 | 137k |
| 20th Mar 2025 2025-03-20T08:25:58 | Appointment of Independent Non-Executive Director | YesNo | 8:25am | 1 | 200k |
| 12th Mar 2025 2025-03-12T11:55:59 | Change of Director's Interest Notice | YesNo | 11:55am | 2 | 237k |
| 11th Mar 2025 2025-03-11T08:23:01 | Transition to Non-Executive Director | YesNo | 8:23am | 1 | 202k |
| 7th Mar 2025 2025-03-07T17:01:18 | S&P DJI Announces March 2025 Quarterly Rebalance | YesNo | 5:01pm | 8 | 179k |
| 27th Feb 2025 2025-02-27T08:06:30 | HY25 Investor Presentation | YesNo | 8:06am | 13 | 1.9M |
About Paragon Care Ltd
Paragon Care Ltd. engages in supplying medical equipment to the health and aged care markets. Its product categories include balance and mobility, beds, mattresses and furniture, carts and trolleys, consulting room equipment, dermatology and cosmetic medicine, general medical products, consumables, infection control, lighting, materials management, newborn care, operating theatre, and ophthalmic. The company was founded in 1994 and is headquartered in South Melbourne, Australia.
PGC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 May 2025 | $0.42 | $-0.01 | -2.33% | 377,348 | $0.43 | $0.43 | $0.41 |
| 12 May 2025 | $0.43 | $-0.01 | -2.27% | 466,363 | $0.43 | $0.44 | $0.42 |
| 09 May 2025 | $0.44 | $0.00 | 0.00% | 570,994 | $0.45 | $0.45 | $0.42 |
| 08 May 2025 | $0.44 | $0.02 | 4.76% | 616,620 | $0.42 | $0.45 | $0.41 |
| 07 May 2025 | $0.42 | $0.00 | 0.00% | 836,111 | $0.41 | $0.43 | $0.39 |
| 06 May 2025 | $0.42 | $0.00 | 0.00% | 490,013 | $0.43 | $0.44 | $0.42 |
| 05 May 2025 | $0.42 | $-0.02 | -4.60% | 467,552 | $0.45 | $0.45 | $0.42 |
| 02 May 2025 | $0.44 | $0.02 | 4.76% | 252,969 | $0.42 | $0.45 | $0.42 |
| 01 May 2025 | $0.42 | $0.00 | 0.00% | 13,056 | $0.42 | $0.42 | $0.41 |
| 30 Apr 2025 | $0.42 | $0.01 | 2.44% | 196,793 | $0.40 | $0.42 | $0.40 |
| 29 Apr 2025 | $0.41 | $0.01 | 2.50% | 127,705 | $0.41 | $0.41 | $0.41 |
| 28 Apr 2025 | $0.40 | $0.00 | 0.00% | 417,441 | $0.41 | $0.41 | $0.40 |
| 24 Apr 2025 | $0.40 | $0.00 | 0.00% | 161,736 | $0.40 | $0.41 | $0.40 |
| 23 Apr 2025 | $0.40 | $0.01 | 2.56% | 45,382 | $0.41 | $0.41 | $0.40 |
| 22 Apr 2025 | $0.39 | $-0.01 | -2.50% | 29,933 | $0.40 | $0.40 | $0.39 |
| 17 Apr 2025 | $0.40 | $0.01 | 2.53% | 168,067 | $0.40 | $0.41 | $0.39 |
| 16 Apr 2025 | $0.40 | $0.00 | 0.00% | 90,328 | $0.39 | $0.40 | $0.39 |
| 15 Apr 2025 | $0.40 | $0.01 | 2.60% | 214,907 | $0.39 | $0.41 | $0.39 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 11 Mar 2025 | Carmen Riley | Buy | 100,000 | $41,000 |
On-market trade.
|
| 02 Dec 2024 | John Walstab | Sell | 14,000,000 | $7,000,000 |
On-market trade.
|
| 27 Nov 2024 | Carmen Riley | Issued | 2,214,267 | $1,096,062 |
Issue of securities. 2,214,267 Performance Rights
|
| 03 Jun 2024 | John Walstab | Issued | 28,594,409 | $11,151,819 |
Issue of securities. As per announcement on 05-06-2024
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Peter Andre Lacaze | Non-Executive ChairmanNon-Executive Director | Jun 2024 |
Mr Lacaze has been involved in CH2 Holdings since 2006 as a minority shareholder and was the Chief Executive Officer between 2006 to 2008. Peter became the Chairman of CH2 Holdings in December 2015 when David Collins and Peter acquired 100% of CH2 Holdings. As an experienced Australian business leader, Peter has worked in a number of industries with particular emphasis on healthcare and travel. Peter brings a dynamic and practical approach with a long-term lens on driving business performance. He is member of Risk Committee.
|
| Mr Michael Sapountzis | Company Secretary | Nov 2024 |
--
|
| Ms Carmen Rose Riley | Chief Operating OfficerExecutive Director | Jun 2024 |
Ms Riley was appointed Chief Operating Officer in 2017 after transitioning from General Manager of Sales. Before joining CH2 Holdings Carmen was CEO of PQ Lifestyles (Intouch) from July 2008, which was successfully acquired by CH2 Holdings in 2010. Prior to joining the Healthcare industry Carmen had a career within FMCG, including Supply Chain and Operations, Finance and Project Management. Carmen's experience provides strong financial and operational management skills gained from both private and ASX listed companies. She is Chair pf Risk Committee.
|
| Mr David Keith Collins | Chief Executive OfficerManaging Director | Jun 2024 |
Mr Collins was appointed as CEO and Managing Director in December 2015 of CH2 Holdings when David and Peter Lacaze acquired 100% of CH2 Holdings. David has been with CH2 Holdings since 2005 starting as Chief Financial Officer and then moving into the Managing Director role in 2008 until 2014. In 2006 David became a minority shareholder of CH2 Holdings. David spent 14 months as the Chief Financial Officer at Greencross Health Limited in Auckland. David brings experience and knowledge of the Australian and New Zealand healthcare wholesale and distribution sectors.
|
| Mr Peter John Egglestone | Non-Executive Director | Mar 2025 |
Mr Egglestone is a senior executive and has more than 25 years leadership, financial and commercial experience. Peters most recent role was CEO of one of Australias payment facilitators. In addition, Peter has held a number of C-Suite positions including for private equity business Journey Beyond, where he led all revenue functions, including sales, marketing, revenue management and customer relations.Peter has a finance and economics background.
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Cherie Maria Millar & David Keith Collins <Collins Millar Family> | 471,762,036 | 28.50% |
| Peter Andre Lacaze & Dianne Maree Lacaze <Lacaze Family> | 471,762,036 | 28.50% |
| Mr John Walstab(i) | 157,956,314 | 9.54% |
| Citicorp Nominees Pty Limited | 83,356,419 | 5.04% |
| HSBC Custody Nominees (Australia) Limited | 72,799,499 | 4.40% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 46,875,287 | 2.83% |
| First Samuel Ltd ACN 086243567 <ANF ITS MDA Clients A/C> | 20,145,625 | 1.22% |
| J P Morgan Nominees Australia Pty Limited | 12,992,454 | 0.78% |
| Certane CT Pty Ltd <Hayborough OPP Fund> | 11,000,000 | 0.66% |
| Phillip Graham Sidney Pty Ltd <Sidney Super Fund A/C> | 8,602,020 | 0.52% |
| Realm Group Pty Limited | 7,520,575 | 0.45% |
| BNP Paribas Noms Pty Ltd | 5,620,955 | 0.34% |
| Negroni Holdings Pty Ltd <The DFN A/C> | 4,727,531 | 0.29% |
| BNP Paribas Nominees Pty Ltd <HUB24 Custodial Serv Ltd> | 4,637,414 | 0.28% |
| Dixson Trust Pty Limited | 4,506,994 | 0.27% |
| Mrs Sandra Joan McDonald & Mr Andrew McDonald <McDonald Family S/Fund A/C> | 4,502,524 | 0.27% |
| JMT Investment Group VIC Pty Ltd <John Turner Super Fund A/C> | 4,500,000 | 0.27% |
| Rathvale Pty Limited | 4,152,250 | 0.25% |
| JMT Investment Group VIC Pty Ltd | 4,000,000 | 0.24% |
| Mr Richard Albarran | 3,942,129 | 0.24% |
| Mr Drew Townsend | 3,942,128 | 0.24% |